de Dios N, Rodríguez http://orcid.org/0000-0002-2766-5972
Moñino A, Martínez
Liu, Cristina
Jiménez, Rafael
Antón, Núria
Prieto, Miguel
Amorelli, Francesco
Foro, Palmira http://orcid.org/0000-0001-8578-3777
Algara, Manuel http://orcid.org/0000-0002-0500-9202
Sanz, Xavier http://orcid.org/0000-0003-2296-9659
Membrive, Ismael http://orcid.org/0000-0003-3113-7475
Reig, Ana
Quera, Jaume
Fernández-Velilla, Enric http://orcid.org/0000-0001-9383-4095
Pera, Oscar
Article History
Received: 13 September 2022
Accepted: 24 September 2022
First Online: 4 October 2022
Declarations
:
: Núria Rodríguez de Dios reports personal fees from AstraZeneca, and Siemens Healthcare outside the submitted work. Manuel Algara reports personal fees from Siemens Healthcare and Sysmex outside the submitted work. Enric Fernández-Velilla reports personal fees from Siemens Healthcare outside the submitted work. All other authors declare no competing interests.
: Patients signed the IC to receive HA-PCI according to the routine clinical practice of the department. The analysis of plans was done retrospectively